These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23953914)

  • 21. Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia.
    Yang Y; Takeuchi S; Hofmann WK; Ikezoe T; van Dongen JJ; Szczepański T; Bartram CR; Yoshino N; Taguchi H; Koeffler HP
    Leuk Res; 2006 Jan; 30(1):98-102. PubMed ID: 16039715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
    Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
    Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
    Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The expression and clinical significance of miR-203 in pediatric acute leukemia].
    Wang N; Pan J; Cao L; Lu J; Xiao PF; Zhao WL; Hu SY; Chai YH
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):777-81. PubMed ID: 24103876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
    Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.
    Mai H; Liu X; Chen Y; Li C; Cao L; Chen X; Chen S; Liu G; Wen F
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):497-504. PubMed ID: 26501552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
    Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
    Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.
    Mulero-Navarro S; Carvajal-Gonzalez JM; Herranz M; Ballestar E; Fraga MF; Ropero S; Esteller M; Fernandez-Salguero PM
    Carcinogenesis; 2006 May; 27(5):1099-104. PubMed ID: 16410262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the methylation of p15 gene CpG islands in acute leukemia: using methylation-specific PCR method].
    Zhang Y; Lou F; Yu L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):628-30. PubMed ID: 11721363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
    J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Spicuglia S
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3835-40. PubMed ID: 24548444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.
    Nordlund J; Bäcklin CL; Wahlberg P; Busche S; Berglund EC; Eloranta ML; Flaegstad T; Forestier E; Frost BM; Harila-Saari A; Heyman M; Jónsson OG; Larsson R; Palle J; Rönnblom L; Schmiegelow K; Sinnett D; Söderhäll S; Pastinen T; Gustafsson MG; Lönnerholm G; Syvänen AC
    Genome Biol; 2013 Sep; 14(9):r105. PubMed ID: 24063430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylome analysis of acute lymphoblastic leukemia cells reveals stochastic de novo DNA methylation in CpG islands.
    Wahlberg P; Lundmark A; Nordlund J; Busche S; Raine A; Tandre K; Rönnblom L; Sinnett D; Forestier E; Pastinen T; Lönnerholm G; Syvänen AC
    Epigenomics; 2016 Oct; 8(10):1367-1387. PubMed ID: 27552300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor.
    Sakamoto LH; Andrade RV; Felipe MS; Motoyama AB; Pittella Silva F
    Leuk Res; 2014 Apr; 38(4):496-502. PubMed ID: 24631370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Salvatore S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.